• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ALINITY C CALCIUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ALINITY C CALCIUM Back to Search Results
Model Number 07P5730
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/02/2020
Event Type  malfunction  
Manufacturer Narrative
Patient identifier: multiple.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer obtained a falsely elevated alinity c calcium result for multiple patients.The customer uses a normal range of 8.5 to 10.5 mg/dl.The following results were provided: on (b)(6) 2020 sample id (b)(6), (b)(6) year old male: 15.4 mg/dl, repeat 8 mg/dl and subsequent result of 8.3 mg/dl.On (b)(6) 2020 sample id (b)(6), (b)(6) year old male: 16.3 mg/dl and normal subsequent results that ranged from 7.7 to 8.7 mg/dl.On (b)(6) 2020 sample id (b)(6), (b)(6) year old male: 15.9 mg/dl and normal subsequent results that ranged from 8.2 to 9.2 mg/dl.On (b)(6) 2020 sample id (b)(6), (b)(6) year old male: 14.7 mg/dl and normal subsequent results that ranged from 7.6 to 7.9 mg/dl.On (b)(6) 2020 sample id (b)(6), male: 15.1 mg/dl and the previous result was 9.9 mg/dl no impact to patient management was reported.
 
Manufacturer Narrative
A review of tickets determined that there is normal complaint activity for alinity calcium reagent lot number 37978un19.Trending data for the alinity c calcium assay was reviewed and determined there were no trend for discrepant patient results.Return testing was not completed as returns were not available.Review of data provided by the customer indicates retesting of the samples on the same instrument gave expected results.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on the investigation, no systemic issue or deficiency of the alinity calcium reagent lot number 37978un19 was identified.
 
Manufacturer Narrative
An additional discrepant result was provided on (b)(6)2020.The new information was added to section b5.An evaluation is still in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
On (b)(6)2020 an additional falsely elevated alinity c calcium result was provided.Sample id 23954659 for a 67 year old female generated 14.9 and repeat of 9.6 mg/dl which matched the patient's previous results.
 
Manufacturer Narrative
On (b)(6)2020 the reagent lot in use was provided.Section d4 lot# was changed from unknown to (b)(6)2019.No other updates were needed.An evaluation is still in process.A follow-up report will be submitted when the evaluation is complete.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY C CALCIUM
Type of Device
CALCIUM
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key10209082
MDR Text Key230614171
Report Number3002809144-2020-00536
Device Sequence Number1
Product Code CJY
UDI-Device Identifier00380740135409
UDI-Public00380740135409
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup,Followup,Followup
Report Date 09/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/23/2020
Device Model Number07P5730
Device Catalogue Number07P57-30
Device Lot Number37978UN19
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/11/2020
Initial Date FDA Received06/29/2020
Supplement Dates Manufacturer Received07/07/2020
08/03/2020
09/10/2020
Supplement Dates FDA Received07/28/2020
08/19/2020
09/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALINITY C PROCESSING MODULE, LIST 03R67-01,; ALINITY C PROCESSING MODULE, LIST 03R67-01,; ALINITY C PROCESSING MODULE, LIST 03R67-01,; ALINITY C PROCESSING MODULE, LIST 03R67-01,; SERIAL (B)(6); SERIAL (B)(6); SERIAL NUMBER (B)(6); SERIAL NUMBER (B)(6)
-
-